News and Events

ANI Pharmaceuticals and Sofgen Announce FDA Approval of Nimodipine 30mg Capsules

BAUDETTE, Minn.July 27, 2015 /PRNewswire/ -- ANI Pharmaceuticals, Inc. ("ANI") (NASDAQ: ANIP) today announced that its ANDA collaboration partner Sofgen has received approval from the U.S. Food and Drug Administration (FDA) of the Abbreviated New Drug Application (ANDA) for Nimodipine 30mg Capsules. Trailing twelve-month sales for the product are $25 million, according to IMS Health, with two current competitors.  ANI and Sofgen expect to begin shipping to customers this year.